Org 5568104755GöteborgResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20101 employees
Revenue 2024
SEK 1,8M
+181% vs 2023
EBITDA margin
0.0%
-80% vs 2023
Equity ratio
1.0%
Financial strength
Net profit 2024
SEK 268
-90% vs 2023
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 1,8M
+181%
EBITDA
SEK 636
-80%
Net profit
SEK 268
-90%
Total assets
SEK 50,6M
+884%
Equity
SEK 515K
+0%
Employees
1
—
Company information
Legal name
ADD Accelerated Drug Development AB
Org number
5568104755
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 juni 2010
Share capital
SEK 500 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av externa firmatecknaren
Company purpose
Bolaget skall utveckla och implementera innovationer och teknologier som bidrar till en mer effektiv läkemedels- och terapiutveckling globalt och därmed förenlig verksamhet.
Contact
Address
Göteborg
Email
niclas@adlerindustries.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.